GlassScriptPhysician profile
Maryemily Haas
NPI 1003170572
$472.63
in general payments reported to CMS, 2019-2025
11 companies · $240 in 2025
The $240 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.75 · 2021: $99.16 · 2022: $13.35 · 2024: $74.24 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $123.85 | 2025 | |
| Merck Sharp & Dohme LLC | $112.64 | 2021-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Gilead Sciences, INC. | $54.66 | 2025 | |
| Alkermes, INC. | $45.75 | 2019 | |
| Amarin Pharma, INC. | $42.00 | 2021 | |
| Dexcom, INC. | $19.81 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $16.70 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $15.27 | 2025 | Aptima, Thinprep 2000 Processor |
| Glaxosmithkline, LLC. | $15.00 | 2025 | Bexsero, Penmenvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.60 | 2024 | Jardiance, Tradjenta |
| Indivior INC. | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryemily Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.